• mtc-call-for-sessions_advamed-homepage.jpg

Top News

Statement | December 10, 2018
Washington, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker as the House Ways and Means Committee released legislation that includes an extension of the moratorium on the medical device tax for an additional 5 years:
Press Release | December 5, 2018
Washington, D.C. – More than 140 patient advocacy, disability, research, community, and health care industry organizations are calling on Congress to permanently repeal the medical device tax before the end of this year.
Press Release | December 3, 2018
Washington, D.C. – MedTech R&D leaders are adopting a variety of strategies to navigate the changing U.S. health care ecosystem, according to a new study from the Deloitte Center for Health Solutions and the Advanced Medical Technology Association (AdvaMed).


February 12, 2019 | Virtual
Human factors and usability engineering aim to optimize the interactions between people and devices, which have grown nearly ubiquitous in recent years. Since 1996, the U.S. Food and Drug... Read More

Industry News

RTI Surgical®
ALACHUA, Fla., – RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, and Paradigm Spine, LLC, a leader in motion preservation and non-fusion spinal implant technology, today announced that they have entered into a definitive agreement whereby RTI will acquire all outstanding equity interest of Paradigm Spine in a cash and stock transaction valued at up to $300 million, consisting of $150 million at closing plus potential future milestone payments. RTI believes this transaction...
Med-Tech Innovation News
The report, from a coalition of stakeholders including leaders from patient groups, academia, government and the private sector, makes several recommendations in an attempt to improve and expand access to advanced radiotherapy services in the UK.
PR Newswire
SAN DIEGO, CA ., Aug. 23, 2018 - Dthera™ Sciences, the leading digital therapeutic company focusing on the elderly and individuals with neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation to the Company's development-stage product, DTHR-ALZ.
Stat News
If your health care is covered by Medicare, like more than 55 million of your fellow Americans, where you live partly determines what Medicare will pay for. The process for deciding what items and services are covered from region to region needs reform.
PR Newswire
SAN ANTONIO, TX., May 23, 2018 - CeloNova BioSciences, Inc. (CeloNova), a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced 1-year clinical trial results from the eCOBRA post-market study of the company's COBRA PzF™ NanoCoated Coronary Stent (NCS) System. The clinical trial results demonstrated 4.3% target lesion revascularization, 0.3% late stent thrombosis and 8.6% major adverse...

Twitter Feed

December 11, 2018 - 4:01pm
The medical device tax forces manufacturers to cut staff, scale back important medical research, or go out… https://t.co/ROMPgZOCE3
December 11, 2018 - 3:01pm
This “pacemaker for the brain” uses electrical pulses to identify and stop seizures before they happen. https://t.co/WvJqQgXeV1